These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Halofantrine in the treatment of falciparum malaria.
    Author: Patel KH, Shastri H, Patel RZ, Parikh PJ, Patel HR, Pathak KJ.
    Journal: Indian J Malariol; 1995 Mar; 32(1):1-5. PubMed ID: 8549834.
    Abstract:
    50 patients (45 males + 5 females) suffering from acute uncomplicated attack of Plasmodium falciparum (Pf) malaria were treated with 1500 mg of halofantrine divided in three doses of 500 mg each given at an interval of 6 h. Results showed there were no primary treatment failures. Average Parasite Clearance Time (av. PCT) was 51.12 h and average Fever Clearance Time (av. FCT) was 31.25 h. Adverse Drug Reactions (ADR) were mild and self limiting. We conclude that halofantrine is a quite safe and effective new antimalarial agent in the treatment of Pf malaria cases.
    [Abstract] [Full Text] [Related] [New Search]